Breaking News Instant updates and real-time market news.

ARNA

Arena Pharmaceuticals

$30.89

-0.61 (-1.94%)

07:31
03/20/18
03/20
07:31
03/20/18
07:31

Arena Pharmaceuticals price target raised to $60 from $53 at Wells Fargo

Wells Fargo analyst Jim Birchenough raised his price target for Arena Pharmaceuticals to $60 form $53 following positive OASIS phase 2 data for etrasimod in ulcerative colitis. The analyst reiterates an Outperform rating on the shares.

ARNA Arena Pharmaceuticals
$30.89

-0.61 (-1.94%)

03/15/18
SBSH
03/15/18
NO CHANGE
SBSH
Buy
Arena heart rate comment not cause for concern, says Citi
Citi analyst Joel Beatty says some investors are asking about a comment made by Arena Pharmaceuticals management on yesterday's earnings call regarding the heart rate effects of S1P modulators being on target effect of the class. The concern seems to be whether this was a change in tone by management that suggests the Phase 2 data expected for etrasimod later this month will show a side effect of slow heart rate, Beatty tells investors in a research note. Beatty asked Arena CEO about this and learned that he has not seen any blinded data from any of the ongoing studies of etrasimod. As such, the analyst believes the comment made on the call doesn't have any direct read-through to the data coming later this month. He keeps a Buy rating on Arena.
03/20/18
PIPR
03/20/18
NO CHANGE
Target $95
PIPR
Neutral
Arena data looks competitive to Celgene's ozanimod, says Piper Jaffray
Last night's data from Arena Pharmaceuticals' (ARNA) competitor to Celgene's (CELG) ozanimod looks at least comparable to if not slightly advantageous versus ozanimod in previously treated ulcerative colitis, Piper Jaffray analyst Christopher Raymond tells investors in a research note titled "Ozanimod's Competitive Outlook Just a Little Bit Less Clear With New ARNA Data." The analyst says that while there is "no perfect apples to apples comparison," Arena's etrasimod, at the very least, is competitive with ozanimod. He prefers to remain on the sidelines with respect to Celgene shares, noting consensus still models "sizeable uptake" for ozanimod. Raymond has a Neutral rating on Celgene with a $95 price target.
03/20/18
JPMS
03/20/18
NO CHANGE
Target $48
JPMS
Neutral
Arena Pharmaceuticals target raised to $48 on positive data at JPMorgan
JPMorgan analyst Jessica Fye raised her price target for Arena Pharmaceuticals to $48 from $45 citing the positive efficacy data in last night's Phase II study results for ulcerative colitis. The likelihood of Phase III success should be considered higher based on the data, Fye tells investors in a research note. While not the pure "best case" scenario with no second degree heart block, the dataset represents a "clear win relative to expectations," the analyst adds. Fye sees the news as a "key positive step" in the ongoing evolution of Arena. The analyst keeps a Neutral rating on the shares.
03/20/18
NEED
03/20/18
UPGRADE
NEED
Buy
Arena Pharmaceuticals upgraded to Buy from Hold at Needham

TODAY'S FREE FLY STORIES

PKD

Parker Drilling

$1.12

(0.00%)

11:39
12/12/18
12/12
11:39
12/12/18
11:39
Hot Stocks
Breaking Hot Stocks news story on Parker Drilling »

Parker Drilling trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$146.29

4.22 (2.97%)

11:37
12/12/18
12/12
11:37
12/12/18
11:37
Periodicals
Facebook and ZeniMax settle VR copyright lawsuit, Engadget says »

Facebook and ZeniMax have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$88.18

-1.31 (-1.46%)

11:36
12/12/18
12/12
11:36
12/12/18
11:36
Earnings
Lowe's sees FY19 EPS $6.00-$6.10, consensus $5.91 »

Sees FY19 total sales up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

LOW

Lowe's

$88.16

-1.33 (-1.49%)

11:35
12/12/18
12/12
11:35
12/12/18
11:35
Earnings
Lowe's Lowe's sees FY18 adj. EPS $5.08-$5.13, consensus $5.11 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

LOW

Lowe's

$88.42

-1.07 (-1.20%)

11:34
12/12/18
12/12
11:34
12/12/18
11:34
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

LOW

Lowe's

$88.42

-1.07 (-1.20%)

11:34
12/12/18
12/12
11:34
12/12/18
11:34
Hot Stocks
Lowe's announces new $10B share repurchase program »

Underscoring its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

RIG

Transocean

$8.47

0.395 (4.89%)

11:31
12/12/18
12/12
11:31
12/12/18
11:31
Hot Stocks
Breaking Hot Stocks news story on Transocean »

Asia Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$37.67

1.08 (2.95%)

11:30
12/12/18
12/12
11:30
12/12/18
11:30
Options
Aggressive call buys in AIG »

Aggressive call buys in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$15.47

-0.03 (-0.19%)

11:29
12/12/18
12/12
11:29
12/12/18
11:29
Recommendations
Intra-Cellular analyst commentary  »

Intra-Cellular price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Sep

JCOM

j2 Global

$70.35

1.09 (1.57%)

11:27
12/12/18
12/12
11:27
12/12/18
11:27
Hot Stocks
j2 Global mentioned cautiously in new GlassHouse Research short report »

GlassHouse Research has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

LOW

Lowe's

$88.53

-0.96 (-1.07%)

11:27
12/12/18
12/12
11:27
12/12/18
11:27
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

11:25
12/12/18
12/12
11:25
12/12/18
11:25
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail Hardlines Analyst…

AVYA

Avaya

$17.78

0.305 (1.75%)

11:24
12/12/18
12/12
11:24
12/12/18
11:24
Hot Stocks
Avaya targets long-term non-GAAP revenue growth CAGR of 2%-4% »

Among other long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

AVYA

Avaya

$17.78

0.305 (1.75%)

11:22
12/12/18
12/12
11:22
12/12/18
11:22
Earnings
Avaya sees FY19 non-GAAP revenue $3.05B-$3.15B, consensus $3.09B »

Sees FY19 non-GAAP gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

TME

Tencent Music

$0.00

(0.00%)

11:20
12/12/18
12/12
11:20
12/12/18
11:20
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AVYA

Avaya

$17.78

0.305 (1.75%)

11:18
12/12/18
12/12
11:18
12/12/18
11:18
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/12/18
12/12
11:17
12/12/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/12/18
12/12
11:16
12/12/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$36.28

1.31 (3.75%)

11:10
12/12/18
12/12
11:10
12/12/18
11:10
Options
Call buyers in Tapestry as shares advance from 52-week lows »

Call buyers in Tapestry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$160.17

1.86 (1.17%)

11:07
12/12/18
12/12
11:07
12/12/18
11:07
Hot Stocks
Accenture to acquire digital media services company Adaptly »

Accenture announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

11:05
12/12/18
12/12
11:05
12/12/18
11:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

JCOM

j2 Global

$71.15

1.89 (2.73%)

11:04
12/12/18
12/12
11:04
12/12/18
11:04
Periodicals
j2 Global mentioned cautiously in short report from GlassHouse Research »

GlassHouse Research…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

PKD

Parker Drilling

$1.12

(0.00%)

11:04
12/12/18
12/12
11:04
12/12/18
11:04
Hot Stocks
Parker Drilling enters Chapter 11 under restructuring support agreement »

Parker Drilling Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.52

-1.33 (-2.26%)

, BAC

Bank of America

$24.57

-0.01 (-0.04%)

11:01
12/12/18
12/12
11:01
12/12/18
11:01
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

VZ

Verizon

$57.52

-1.33 (-2.26%)

BAC

Bank of America

$24.57

-0.01 (-0.04%)

MS

Morgan Stanley

$41.00

0.38 (0.94%)

TSLA

Tesla

$368.00

1.37 (0.37%)

ROKU

Roku

$35.66

-0.16 (-0.45%)

CORT

Corcept Therapeutics

$18.72

1.56 (9.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 18

    Dec

  • 19

    Dec

  • 12

    Feb

EFA

iShares MSCI EAFE Index Fund

$61.52

1.04 (1.72%)

11:00
12/12/18
12/12
11:00
12/12/18
11:00
Options
Million dollar straddle purchase in iShares EAFE International ETF »

Million dollar straddle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.